MIR4762

Across TCGA pan-cancer cohorts, MIR4762 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR4762’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where MIR4762 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR4762 is over-expressed in tumor, although a few such as UCEC and ESCA show the opposite, repressed pattern.

UCEC, HNSC, and ESCA are the cancer types where MIR4762 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4762 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	IV	−1.490	.001	2	view →
HNSC	All	II,III,IV	+0.082	.044	2	view →
ESCA	Female	All	−0.633	.031	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR4762–UCEC

Open the UCEC breakdown →